Overview

Gender

male

Investor Type

Investment Partner

Dr. Geiger brings extensive entrepreneurial, management and investment know-how creating and building many successful businesses.

Dr. Geiger co-founded Accelmed together with Mori Arkin in 2009 with the goal of forming a leading investment company solely dedicated to the medical device industry.

Until January 2009, Dr. Geiger served as the CEO of Exalenz Bioscience Ltd. (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders that he acquired from Oridion Systems (today part of Covidien) and took public in 2007.

He previously co-founded and was the CEO of GalayOr Networks, a developer of optical components which was sold in 2003 to MEMSCAP (EuroNext: MEMS).

Dr. Geiger is also the founding partner of Dragon Variation Fund, one of Israel's first hedge funds which was sold to Migdal in 2007.

Prior to returning to Israel in 1999, Dr. Geiger gained a broad understanding and experience in capital markets working on Wall-street during the 1990s.

Dr. Geiger was formerly an adjunct professor at Tel Aviv University's Recanati School of Business where he lectured on private equity and venture capital and he is the author of the books "Startup Companies and Venture Capital" (Tel Aviv University Press, 2001) and "From Concept to Wall Street" (Financial Times - Prentice Hall, 2003).

He earned his doctorate from New York's Columbia University Center for Law & Economics, with a concentration in global equity markets. Dr. Geiger served as a major (Ret.) in the Israeli Air force.